(CNN) — Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.
The arrangements with drugmakers Eli Lilly and Novo Nordisk, which President Donald Trump foreshadowed in remarks last month, are the latest in the administration’s efforts to lower drug prices. As part of the new deals, the drugmakers have also agreed to match prices to the lowest paid in peer nations for all their drugs in Medicaid as well as for the list prices when their medications first hit the market. They will also offer primary care medicines directly to consumers at discounted prices.
In exchange, the drugmakers are getting breaks on tariffs on imported pharmaceutical p

WKOW 27

Local News in Massachusetts
America News
Associated Press Top News
CNN Politics
Reuters US Top
Raw Story
Detroit Free Press
AlterNet